摘要 |
<p>5-Amino-1-(hydroxymethyl)cyclopentane-1,2,3,4-tetraol and 2-amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole- 4,5,6-triol, which have the ability to inhibit the activity of sugar hydrolases, especially beta -glucosidase and sucrase, and which can thus be used for the treatment and prophylaxis of tumorous conditions, AIDS, diabetes and obesity, can be prepared by hydrolysis of trehazolin. 2-Amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole- 4,5,6-triol can also be prepared by fermentation using newly isolated strains Micromonospora sp. SANK 62390, FERM BP-3521 and Amycolatopsis sp. SANK 60791, FERM BP-3513.</p> |
申请人 |
SANKYO COMPANY LIMITED |
发明人 |
MUTSUO, NAKAJIMA C/O SANKYO COMPANY LIMITED;OSAMU, ANDO C/O SANKYO COMPANY LIMITED;SHUJI, TAKAHASHI C/O SANKYO COMPANY LIMITED;KIYOSHI, HAMANO C/O SANKYO COMPANY LIMITED;HIDEYUKI, HARUYAMA C/O SANKYO COMPANY LIMITED;TAKESHI, KINOSHITA C/O SANKYO COMPANY LIMITED;AKIRA, SATO C/O SANKYO COMPANY LIMITED;YASUYUKI, TAKAMATSU C/O SANKYO COMPANY LIMITED;RYUZO, ENIKITA C/O SANKYO COMPANY LIMITED |